Masahiro Uehara
- Hepatology top 10%
- Hepatitis C virus research 3
-
- Colorectal Cancer Treatments and Studies 3
-
- Wnt/β-catenin signaling in development and cancer 5
- Cancer-related gene regulation 3
-
- Gastric Cancer Management and Outcomes 4
- Metastasis and carcinoma case studies 3
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
-
- Gastrointestinal disorders and treatments 4
- Co-authors
- Takahiro DomotoToshinari MinamotoSadako Akashi‐TanakaTakayuki KinoshitaTakashi HojoEriko IwamotoTakashi FukutomiKatsuyoshi Miyashita
- Cited by
- HepatologyCancer ResearchOncology
In The Last Decade
Masahiro Uehara
38 papers receiving 571 citations
Peers
Comparison fields: 5 of 87
- Hepatology 67
- Cancer Research 118
- Oncology 150
- Molecular Biology 276
- Pulmonary and Respiratory Medicine 108
Countries citing papers authored by Masahiro Uehara
This map shows the geographic impact of Masahiro Uehara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Uehara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Uehara more than expected).
Fields of papers citing papers by Masahiro Uehara
This network shows the impact of papers produced by Masahiro Uehara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Uehara. The network helps show where Masahiro Uehara may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masahiro Uehara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2021 | 14 | |
| 4 | 2020 | 9 | |
| 5 | 2020 | 81 | |
| 6 | 2020 | 1 | |
| 7 | 2020 | 2 | |
| 8 | 2016 | 7 | |
| 9 | 2011 | 1 | |
| 10 | 2009 | 0 | |
| 11 | 2009 | 2 | |
| 12 | 2009 | 13 | |
| 13 | 2008 | 3 | |
| 14 | 2008 | 0 | |
| 15 | 2008 | 108 | |
| 16 | 2007 | 11 | |
| 17 | 2003 | 0 | |
| 18 | 2001 | 25 | |
| 19 | 1998 | 28 | |
| 20 | Clinical study on drug fever without drug eruption. | 1990 | 1 |
About Masahiro Uehara
Masahiro Uehara is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Oncology, having authored 45 papers that have together received 583 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (5 papers), Gastrointestinal disorders and treatments (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer-related gene regulation (3 papers), Metastasis and carcinoma case studies (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Hepatitis C virus research (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Hepatology (67 citations), Cancer Research (118 citations) and Oncology (150 citations). Masahiro Uehara has collaborated with scholars based in Japan, Germany and Greece. Frequent co-authors include Takahiro Domoto, Toshinari Minamoto, Sadako Akashi‐Tanaka, Takayuki Kinoshita, Takashi Hojo, Eriko Iwamoto, Takashi Fukutomi, Katsuyoshi Miyashita, Takeo Shimasaki and Takuya Furuta. Their work appears in journals such as Cancer Science, Scientific Reports, Japanese Journal of Clinical Oncology, BMC Pulmonary Medicine and Nutrition and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.